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1. Introduction  
Complex diseases are common within human populations and communities and pose a 
great burden not only to affected individuals, but also to society and the health system. 
Disorders such as chronic heart disease, diabetes, Alzheimer’s, epilepsy and many others, 
are caused by complex interactions of a number of genetic and environmental factors. This 
makes the identification of the responsible genes difficult if using the same methodologies 
used for monogenic diseases. For more than fifteen years there has been a collective effort by 
researchers from around the world to identify genes and genetic variations that increase the 
risk for osteoporosis and fractures in ageing populations to identify novel therapeutic and 
prognostic targets, but predominantly most studies have been inconclusive. Genetic 
heterogeneity between different populations is the main factor responsible for this lack of 
concordance between different studies. Using different approaches such as association, 
family linkage, genome-wide association and meta-analysis, researchers reported numerous 
genes that might play a role in bone physiology, most of the time searching for correlation 
with phenotypes such as low bone mineral density (BMD) and fractures. Unfortunately, 
most of these genetic variations were not further investigated for their functional role and 
how these could lead to the disease. Some monogenic bone diseases led to the identification 
of genes that were never considered to be involved in bone physiology such as the low 
density lipoprotein receptor-related protein (LRP)-5 (Gong et al., 2001) and sclerostin (SOST) 
genes (Brunkow et al., 2001). 
A genome-wide linkage scan was performed in two Maltese families with a very high 
incidence of osteoporosis, where suggestive linkage to chromosome 11p12 was observed. 
After investigating the genes known to be found at this region by DNA sequencing, we 
identified a variant in the CD44 gene that was co-segregating with the inherited haplotype 
in all affected members within one of the families. Further studies on this variant suggested 
that it could affect pre-messenger RNA splicing, or organisation, leading to different levels 
of slightly modified variants of the same protein (isoforms). Other loci were identified in 
both families. 
Without doubt, the analysis of data would not have been possible without the number of 
bioinformatic tools and software that are available. The advances in computer technology 
including the internet, led to the development of various software and online tools. In this 
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chapter, we will take a look at software and other online tools used in this study. We will 
discuss the basic concepts of the study, how the analysis was performed using different 
software and the interpretation of results.  
1.1 Gene mapping using families 
One of the greatest challenges for geneticists is the identification of genes responsible for 
complex disease. Unlike classical Mendelian disorders, these diseases do not show obvious 
Mendelian patterns of inheritance and involve complex interactions between various 
environmental and genetic factors. Confounding factors such as heterogeneity, phenocopies, 
genetic imprinting and penetrance further complicate the identification of susceptibility genes.  
When performing a genetic study, correlation between phenotype and genotype is sought. 
In complex traits, this correlation might be very low due to incomplete penetrance where 
not all individuals having the same susceptibility allele are affected or where affected 
individuals do not have a susceptibility allele (phenocopies). These factors lead a wide 
ranging severity of disease even within a single family. Further more, late onset diseases 
such as cardiovascular disease and osteoporosis show up later in life and thus unaffected 
individuals tested today might become affected in the near future. Late onset diseases are 
more sensitive to environmental (mostly lifestyle related) factors and are observed to have a 
higher level of genetic variation due to weak selective pressures on these variants that are 
usually neutral early in life (Wright et al., 2003). Besides testing for a qualitative trait where 
individuals are grouped as either having or not having the disease, one can use quantitative 
or a continuous measurement such as BMD. When using a quantitative variable one must be 
very cautious as it might not completely correlate with the disease and it could also be 
dependent on a number of other non-genetic factors including limitations of methodology. 
Complex disorders are most often polygenic where multiple genes contribute to the 
phenotype. Complex patterns of inheritance might be due to allelic or locus heterogeneity 
where different variants within the same gene are responsible for the disease or where a 
number of different genes are involved in the same biological process. When studying 
complex disorders, therefore, one is looking for susceptibility alleles at multiple loci that 
together increase the individual’s risk for the disease. In polygenic traits, penetrance is 
determined by the genotypes of other loci and therefore it is likely to be low and will vary 
between individuals. To increase the chance of successful gene mapping, it is important to 
identify families from probands with extreme phenotypes, earlier age at onset or else to 
study families from an isolated population with a very high incidence of disease. Wright 
and colleagues (2003) suggested that it is important to identify genes with the largest 
contribution to the extremes of the trait and avoid quantitative trait loci (QTL) that have 
minimal effects on the individual or disease mechanism.  Using single extended families 
from populations that are homogeneous and consanguineous has proven to be a successful 
approach in localising the genes and novel mutations in type 2 diabetes (Kambouris, 2005). 
Using one extended family, Kambouris reported similar results to those obtained from 
previous genome-wide scans using hundreds of individuals (Hanson et al., 1998). This 
shows that costs and time to identify novel genes responsible for complex disorders can be 
significantly reduced, when using extended and consanguineous families coming from 
homogeneous populations. 
1.1.2 Linkage analysis  
In linkage analysis, the non-independent co-segregation of marker and disease locus is 
tested in families with multiple affected individuals. Linked alleles (marker with disease- 
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causing allele) on the same chromosome segregate together more often than expected by 
chance; i.e. against Mendel’s law of independent assortment. Gene mapping of a trait 
identifies chromosomal loci that are shared among affected individuals and that differ 
between affected and non-affected family members. Positive linkage can only be obtained 
for marker alleles inherited together with disease allele on the same chromosome. This is a 
major limitation for linkage analysis when different disease alleles present at the same locus 
are on different chromosomes, hence in trans, as in a case of coeliac disease (Vidal et al., 
2009a). In this study, no evidence of linkage was observed to the human major 
histocompatibility complex (MHC) locus on chromosome 6, in a family with high incidence 
of celiac disease. Further investigations showed that this was because inherited risk alleles 
coding for HLA group DQ2.2 occur in trans and so cannot be detected by linkage.  
For a linkage study family members from pedigrees with normal and osteoporotic 
individuals are genotyped for a set of polymorphic markers either across the whole genome 
or at specific chromosomal loci, where known candidate genes are located. Genetic linkage 
is measured by the recombination fraction that is the probability that a parent will produce a 
recombinant offspring and is dependent upon the distance between loci. The more distant 
two markers are from each other the higher is the chance that a recombination event occurs 
between them during meiosis. The recombination fraction theta (θ) ranges from 0 for 
completely linked markers to 0.5 for unlinked loci. Genetic linkage is measured in 
centiMorgans (cM), where 1cM represents 1% recombination or θ = 0.01 that is equivalent to 
1 million base pairs. So using the recombination fraction one can calculate the physical 
distance on the chromosome, although recombination rates might vary depending on 
location on chromosome. Recombination rate is usually lower closer to the centromere. Also 
these measurements might not be so accurate for longer chromosomal distances where 
multiple crossovers might occur during a single meiotic event, a phenomenon known as 
interference. Two mapping functions to convert recombination fraction into map distance 
are Haldane’s, that does not assume interference, and Kosambi’s, which assumes 
interference as 1 - 2θ.  
1.1.3 Parametric linkage analysis 
Parametric linkage analysis is a statistical approach using the logarithm of the odds ratio 
(LOD score) to assess the strength of linkage. This is also known as a model based linkage 
where the mode of inheritance, frequencies of disease and marker loci together with 
penetrance must be known. The statistic assumes the likelihood (or probability) that a 
disease and marker loci in a family are not inherited together (θ = 0.5) compared with the 
likelihood that they are linked over a selected range of recombination fractions (θ range of 0 
to 0.5). The LOD score is the base ten logarithm of the likelihood ratio that is calculated for 
each value of θ. A two point LOD (z) score (between disease locus and marker) is calculated 
using the following equation: 
 z(x) = log10 [L(θ=x) ÷ L(θ=0.5)] (1) 
where x is a value of recombination fraction and L is the likelihood. 
Significant evidence of linkage is taken at a LOD score of 3.0 or higher and linkage is 
completely excluded with a LOD score of -2.5. A LOD score of 3.0 corresponds to odds of 
1000:1 that means that it is 1000 times more likely that the alternate hypothesis in favour of 
linkage holds while a LOD score of 3.5 is equivalent to odds of 3162:1. The LOD score can be 
converted to a chi-square statistic by simply multiplying by 4.6 and calculating a p-value at 
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1 degree of freedom (df) for ordinary LOD and at 2 df for heterogeneity LOD scores 
(HLOD), under the null hypothesis (Ott, 1991). The p-values obtained are always divided by 
2 for one-sided tests except when calculating p-values for multi-point LOD (MLOD). Using 
these calculations a LOD score of 3.0 is equivalent to a p-value of 0.0001 while that of 3.6 is 
equivalent to 0.00002. However, a chi-square derived p-value applies more for large sample 
sizes and can be underestimated when sample size is too small. Lander and Kruglyak (1995) 
suggested that linkage must be reconfirmed by other independent investigators where a 
nominal p value of 0.01 would be required, while they advised caution when reporting LOD 
scores that are less than 3.0 and so are only suggestive of linkage. In case of suggestive 
linkage, additional family data would be required before conclusions can be drawn (Lander 
& Kruglyak, 1995). 
LOD scores can be influenced by a number of factors including the phase or whether 
parental genotypes are known, misspecification of disease and marker allele frequencies, 
penetrance, heterogeneity and mostly by phenotypic misclassification. Also for more 
accurate linkage information and to better localize the disease gene, multi-point linkage 
analysis is preferred over two-point analysis. Statistical analyses in complex pedigrees are 
carried out using software such as MLINK and GENEHUNTER where the LOD score can 
also be adjusted for locus heterogeneity (HLOD) (Kruglyak et al., 1996). 
Another kind of analysis which is thought to be useful when analysing linkage data for 
complex traits is the MOD-score. In complex traits both the genetic model and disease allele 
frequency are very difficult to specify correctly. An incorrect assumption of the genetic 
model can significantly affect the analysis and can lead to a false negative result. The MOD 
score is calculated by maximising the LOD score over a number of replicates using different 
penetrances and disease allele frequencies, to obtain a maximum LOD score using the best 
genetic model (Strauch et al., 2003). To control type I errors, it was found that a MOD-score 
of 3.0 should be adjusted by a value ranging from 0.3 – 1.0 where it was proposed that a 
MOD-score of 2.5 is indicative of suggestive linkage (Berger et al., 2005). MOD-score 
analysis can be used to determine the best genetic model for those regions indicated by an 
initial genome scan using ordinary LODs and it can also be calculated assuming paternal or 
maternal imprinting. When assuming imprinting a heterozygote paternal penetrance is also 
used with the other three penetrances with a total of four penetrance values. If a low 
heterozygote frequency is calculated for paternal imprinting, it indicates that maternal genes 
are preferentially expressed at that locus (Strauch et al., 2005; Berger et al., 2005). 
1.1.4 Non-parametric linkage analysis 
Since the mode of inheritance for complex disorders is uncertain, evidence of linkage might 
be missed by using the LOD score method described above. A more appropriate approach is 
that described by Kruglyak et al (1996) known as a non-parametric linkage (NPL) or a model 
free analysis. The NPL statistic measures allele sharing among affected relative pairs (ARP) 
and/or affected sib-pairs (ASP) within a pedigree. By chance it is expected that siblings 
share zero, one or two marker alleles identical by descent (IBD) with a probability of 0.25, 
0.50 and 0.25, respectively. If disease and marker alleles are linked then affected siblings will 
share these alleles more frequently than expected by chance regardless of the mode of 
inheritance. Comparison between expected and observed allele sharing between ASPs is 
then analysed using the chi-square statistic. Highly heterozygous markers, multipoint 
linkage and genotyping of non-affected siblings when parents are not available help to 
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increase the sharing information. One great advantage of the NPL statistic is that data from 
markers on a chromosome can also be evaluated in a multipoint approach using software 
such as GENEHUNTER which uses the Lander-Green algorithm to calculate IBD 
distribution (Kruglyak, 1996). 
1.2 Phenotype definition, selection of family and population 
1.2.1 Phenotype 
Phenotype definition is one of the most important factors and should be determined by 
proper diagnosis or exclusion of other medical conditions that could lead to the same 
disease. To exclude disease and other factors leading to secondary osteoporosis, individuals 
were asked to answer a questionnaire and a series of other medical tests were performed. 
Measurement of bone mineral density (BMD) together with t-scores (number of standard 
deviations from the mean BMD of a control group of young women at peak bone mass) is 
the gold standard to diagnose osteoporosis, as recommended by World Health Organisation 
(WHO). However, this methodology does not show the whole picture partly because bone 
strength, thus fracture risk, is not completely assessed by measuring bone density. Also, 
individuals with normal BMD, who might become osteoporotic in ten or twenty years time, 
could still carry the responsible allele. As discussed above, miss-classification of affected 
status might seriously affect the results obtained by statistical analysis. To overcome this 
issue, and unlike other linkage studies for osteoporosis, we used different thresholds of t-
scores and z-scores at the lumbar and femoral sites obtained after measuring BMD, to define 
discreet phenotypes as simply affected or not-affected. Statistical analyses were performed 
in five different scenarios defining discreet phenotypes using the guidelines suggested by 
the International Society of Clinical Densitometry (Khan et al., 2004).  
1.2.2 Families 
Extended families with a number of affected individuals are ideal for identifying variants 
with higher penetrance but are less frequently found in populations. Development of novel 
treatments can be targeted to these pathways. Factors such as mode of inheritance, 
penetrance and disease or allele frequencies together with technical factors such as accuracy 
of genotyping, all affect power to detect a significant linkage.  
1.2.3 Population 
The genetic component within a population is strongly affected by its history and 
demography. The genetic pool of a population is determined by mutations, population 
admixture as well as by random genetic drift that occurs most often due to catastrophic 
events that result in a major decrease in population (Wright et al., 1999). Genetically isolated 
populations (by geography and/or culture), that recently expanded from a very small 
number of founders with occasional interbreeding with other ethnic groups, are more likely 
to share haplotypes identical by descent (IBD) over longer genetic distances (Wright et al., 
1999). 
The present Maltese population, although geographically (but not genetically) isolated, is 
thought to have expanded exponentially from a much smaller population during the last 
four hundred years with a possibility of a number of founder effects introduced by 
admixture with other populations coming from Sicily, the eastern Mediterranean and 
northern Africa. Founder effects were reported in the Maltese population, including a 
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mutation (R1160X) found in the NPHS1 gene coding for nephrin that causes nephrotic 
syndrome (Koziell et al., 2002) and the 68G>A mutation within the quinoid 
dihydropteridine reductase gene that causes a rare form of hyperphenylalaninaemia and 
phenylketonuria (Farrugia et al., 2007). The introduction of founder effects and major 
bottlenecks may increase the chance of creating sub-populations with particularly high 
allele frequencies when compared to the rest of the population (Heiman, 2005). Significant 
fluctuations in the population were brought about by emigration of the Maltese in fear of 
further attacks by the Turks, death by famine or plague. On the other hand, the existence of 
a relatively frequent disease in an island population does not necessarily always indicate a 
possible founder effect since this might result from multiple mutations in a single gene or in 
different genes that could lead to the same phenotype (Zlotogora, 2007).  
Genetically isolated populations proved to be very useful for the identification of genes not 
only in the case of the BMP-2 gene in Iceland but also for a number of other diseases 
(Styrkarsdottir et al., 2003). More than 15 mutated genes were successfully identified by 
positional cloning in families from the isolated population of Finland. The Finnish 
population demographic history was characterised by rapid expansion from a much smaller 
population with a number of founder effects (Peltonen, 2000). Another island population 
that proved successful for the identification of a mutation responsible for uric acid 
nephrolithiasis by linkage was the Sardinian population (Gianfrancesco et al., 2003). Linkage 
studies in Maltese families resulted in successful identification of rare genetic variants 
responsible for other human disorders such as coeliac disease (Vidal et al., 2009a), epilepsy 
(Cassar, 2008) and recently in the identification and confirmation of the role played by the 
erythroid transcriptional factor KLF1 in hereditary persistence of foetal haemoglobin (Borg 
et al., 2010). 
2. Materials and methods 
2.1 Patient recruitment 
Two extended families consisting of a total of 27 family members with several individuals 
having low BMD were recruited for this study. Families were selected through index 
patients (or probands) referred to the Bone Density Unit, Department of Obstetrics and 
Gynaecology, St. Luke’s Hospital, Malta for an osteoporosis risk evaluation. The proband in 
Family 1 was a 61-year-old female diagnosed with osteoporosis six years earlier and was 
known to have a family history of osteoporosis. Five out of seven of her siblings were 
recruited while the other two were not willing to participate in the study. Osteoporosis was 
confirmed in all six recruited siblings. All female siblings were osteoporotic at the lumbar 
spine and one male was osteoporotic at the femoral neck. One sibling had an asymptomatic 
compressed vertebral fracture. Three daughters of the proband were recruited (age range 33 
– 38 years) and all of them were found to have very low BMD for their relatively young age. 
Their 37-year-old cousin was also found to have very low BMD at both the lumbar (t-score -
2.25) and femoral neck (t-score -1.07), and had very low body mass index (BMI) (16.2 
kg/m2). It was not possible to collect blood for DNA analysis from this participant. 
The proband in Family 2 was a 55-year-old woman with osteoporosis at the lumbar spine, 
diagnosed five years earlier. A closer investigation of this family revealed four osteoporotic 
siblings out of five. Their children were healthy young adults, some of whom had very low 
BMD relative to their age. The presence of males with low BMD and history of fractures in a 
severely osteoporotic sibling were good indicators that a genetic factor might be involved.  
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As already discussed, five different scenarios were tested using thresholds for t-scores and 
z-scores as previously described (Khan et al., 2004). Osteoporosis for post-menopausal 
women and men over fifty years of age was defined using a lumbar and/or femoral t-score 
of less than -2.50 (WHO criteria). Definition of affected status for younger individuals was 
determined using z-scores of less than -1.0 and less than -2.0 for a more severe phenotype, 
for scenarios III and IV, respectively. For scenario V, analysis was performed using only 
affected individuals having femoral z-scores of less than -1.0. In all five scenarios, family 
members having normal BMD measurements were assumed to have an unknown 
phenotype. This assumption takes into consideration the possibility that any apparently 
clinically unaffected individual might actually be affected, thus reducing the chance of 
obtaining false negative results. 
2.2 Genotyping 
To perform a successful gene mapping study, a number of polymorphic markers have to be 
typed in affected and non-affected individuals to identify genes that increase the risk of 
disease. Different types of genotyping markers were used in recent years and new 
techniques for typing are constantly being developed to increase efficiency, accuracy and 
throughput while reducing costs. 
2.2.1 Microsatellite genotyping 
Short tandem repeats (STRs) or microsatellites are widely distributed in the genome and so 
are useful tools for genome-wide scans. These tandem repeats can be dinucleotide, 
trinucleotide or tetranucleotide repeats where polymorphisms are generated by gain or loss 
of repeats usually as a result of both replication slippage and point mutation. Microsatellites 
have several advantages for typing, the most important of which is that they are highly 
polymorphic with a very high heterozygosity (>70%), so making them ideal for use in 
linkage studies. Another advantage is that they can be very easily typed using PCR 
techniques where fluorescently labelled primers flanking the polymorphic region are 
designed. The variable number of repeats creates amplicons of different sizes which can be 
typed using automated sequencers such as those by Applied Biosystems (ABI) (PE Applied 
Biosystems Division, Foster City, CA). Different sets of markers across the whole genome 
are electronically available from databases such as those of Marshfield Institute of Genetics 
(http://research.marshfieldclinic.org/genetics/), deCode (http://www.decode.com/ 
services/microsatellite-genotyping-genome-wide-scans.php) and the Cooperative Human 
Linkage Centre (http://gai.nci.nih.gov/CHLC/). Markers can be selected from these 
databases either across the whole genome or at candidate loci usually with an average 
spacing of 10cM and for a higher resolution at < 5cM.  To increase throughput and reduce 
costs, the amplified fragments are carefully pooled in sets in such a way that the allele size 
range does not overlap within a set and by using different dyes for different sets.  
An initial genome-wide scan, 400 microsatellite markers spread across the 22 autosomes and 
x-chromosome with an average spacing of 8.63cM and heterozygosity of 0.77, was 
performed. The average performance of markers for all samples was of 96.96%. Fine-
mapping was performed by increasing the markers at indicated loci from the initial scan. 
Genotyping was performed by polymerase chain reaction (PCR) followed by fragment 
analysis using a 3730xl ABI genetic analyser (Applied Biosystems, Foster City, CA, USA). 
The average performance of the markers was of 96.02%. Genotyping was performed 
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commercially at the McGill University and Genome Quebec Innovation Centre, Quebec, 
Canada.  
2.3 Analysis of linkage data  
PedCheck (O’Connell and Weeks, 1998) was used to determine if the inheritance of marker loci 
was according to Mendel’s laws. Multipoint parametric and non-parametric linkage analyses 
were performed using GENEHUNTER-PLUS (Markianos et al., 2001) which is an improved 
version of GENEHUNTER (Kruglyak et al., 1996). GENEHUNTER v1.2 was used to calculate 
Zlr scores according to Kong and Cox (1997). Linkage analysis of markers on the X-
chromosome was performed using a specific application for this chromosome included with 
the GENEHUNTER package. All analyses were performed using EasyLinkage v5.05 
(http://www.uni-wuerzburg.de/nephrologie/molecular_genetics/molecular_genetics.htm) 
(Lindner and Hoffmann, 2005). Parametric analysis was carried out using variable 
penetrances for both a dominant and recessive mode of inheritance. Penetrances used for 
the dominant model were 0.01 for the wild-type homozygote, 0.90 for mutant heterozygote 
and 0.90 for mutant homozygote, respectively. The recessive model was defined by 
penetrances 0.01, 0.01, and 0.80 for the wild-type homozygote, mutant heterozygote and 
mutant homozygote, respectively. A more complex model was also analysed using 
penetrances 0.01, 0.05, 0.30 for wild-type homozygotes, mutant heterozygotes and mutant 
homozygotes, respectively. A parametric analysis assuming heterogeneity was computed 
using data from both families (HLOD). 
A co-dominant allele frequency algorithm was used for the analysis, as suggested in the 
EasyLinkage manual, for extended families. For all models, the disease allele frequency 
assumed was 0.001, and phenocopy rate of 1%. This disease allele frequency is equivalent to 
a population prevalence of 0.2% assuming Hardy-Weinberg equilibrium calculated using 
the following equation (Xu & Meyers, 1998):  
 2(1 – q) q + q2 (2) 
q = disease allele frequency. 
Analysis was performed using other penetrance values for loci showing evidence of linkage 
in the initial genome-wide scan. The exact genetic model was determined using 
GENEHUNTER-MODSCORE v1.1 (Strauch et al, 2005), where MOD scores were calculated 
from simulations of different models and disease allele frequencies with and without 
imprinting. This analysis was suggested by Strauch et al (2003) for complex trait analysis 
and was done only for those regions showing suggestive linkage. The deCode genetic map 
was used throughout the study. 
2.3.1 Using EasyLinkage v5.05 graphical user interface (GUI) 
EasyLinkage is a Microsoft Windows® based GUI, developed in recent years. This was a 
step forward for researchers wanting to perform linkage analysis. Using EasyLinkage and a 
common input file format, one can analyse data using all major software such as PedCheck, 
GENEHUNTER, Merlin and Allegro. EasyLinkage can be used to analyse data generated 
from projects using both single nucleotide polymorphisms (SNPs) as well as STRs. Analysis 
can be performed on chromosome by chromosome or else genome-wide basis, making use 
of the appropriate genetic maps (such as deCode and Marshfield), using male, female or 
sex-averaged maps, from which more accurate genetic positions can be drawn. Both 
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graphical and text output files are automatically generated for each individual family 
together with a collective report averaging all families, in text or pdf formats and stored into 
an appropriately labelled folder showing date and type of analysis. These files show 
statistical analyses results such as LOD scores, NPL, p-values and input parameters given 
by the user for that model including penetrances, disease allele frequencies and genetic 
positions of markers ranked according to the most significant results. 
There are four allele frequency algorithms to choose from depending on the type of analysis 
needed. Several versions of this software have been developed, improving its capabilities to 
handle large amounts of data generated from SNP arrays such as the Affymetrix 500k and 
Illumina 650k chips. For SNP analysis, allele frequencies of all the major ethnic groups form 
part of the EasyLinkage software package.  
2.3.2 Data entry 
There are two main types of files needed to perform linkage analysis using microsatellites or 
STRs. In this study, a qualitative type of analysis was performed using discrete phenotypes 
(affected vs unaffected). One type of input file should contain family or families’ information 
in a standard linkage format. The marker file should include the genotype results for each 
family member. All family or families’ information including pedigree structure has to be 
entered into a pedigree file. Shown below is part of the pedigree file as created in our study 
(only obligatory columns were used). From left to right columns represents (i) unique family 
identifier; (ii) individual unique identifier (iii) father and (iv) mother identifiers; (v) sex 
identification code (1=male, 2=female, 0=unknown); (vi) affected status (1=unaffected, 
2=affected, 0=unknown). In case parents are unknown then enter ‘0`. As explained previously 
is an unknown phase and so it reduces the power of the study, even though the software is 
able to assume the genotypes of these individuals using the known genotypes from their 
offspring (inferred genotypes). An example for using the unknown option in column (v) is 
when you do not know the sex of a child due to death in utero. 
 
A_1 A_1_01 A_1_11 A_1_12 2 2 
A_1 A_1_02 A_1_11 A_1_12 1 2 
A_1 A_1_03 A_1_11 A_1_12 2 2 
A_1 A_1_10 0 0 1 0 
A_1 A_1_11 0 0 1 0 
A_2 A_2_11 A_2_28 A_2_29 1 1 
A_2 A_2_12 A_2_28 A_2_29 2 2 
 
Phenotype definition has to be done using appropriate criteria and diagnostic tests, for 
example in our study, measurements of BMD together with blood tests were used to exclude 
other medical conditions that could also affect BMD. In complex disorders, it might be 
difficult to define the phenotype correctly and this could seriously affect the outcome of 
results. Select 1 and 2 wherever diagnostic tests were performed and phenotype is known. 
Any individuals not tested should be defined as having an unknown status. This is a better 
option because individuals wrongly defined as normal could give a false negative result 
(type II error) as these might be carrying the causative alleles and might become affected at a 
later stage in their life. As described in the phenotype definition section, we analysed our 
data using five different scenarios defined by t-scores and z-scores. For each scenario a 
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different pedigree file was created and saved in a folder together with the marker files 
described in the next section.  
Creating marker files 
Marker files should include genotyping results for all family members tested. Entering data 
is the most laborious part of the study because different files have to be created for each 
marker, i.e. if 400 markers were tested then 400 different marker files have to be created and 
saved in the same folder together with pedigree files. These files should be named with the 
marker identification corresponding with that in the marker map file (.map) used by the 
software e.g. ‘D1S200_FINAL.abi`. If the marker is not found within the marker map file 
then an error is given when running the analysis. This error can be corrected manually by 
adding the marker into the marker map file found in the EasyLinkage folder in Program 
Files.  
This is an example of the method used to input data into marker files: 
 
MARKER LANE ID A_1 A_2 
D1S200 A1 A_1_01 165 176 
D1S200 A2 A_1_02 161 176 
D1S200 A3 A_1_03 165 176 
D1S200 A4 A_1_04 161 176 
D1S200 A5 A_1_05 161 176 
D1S200 A6 A_1_06 161 176 
D1S200 B1 A_2_10 161 176 
D1S200 B2 A_2_11 161 176 
D1S200 B3 A_2_12 161 161 
 
Column (i) name of marker e.g. D1S200; (ii) PCR reaction position in a 96-well PCR plate 
(information not used by software); (iii) individual identification number corresponding 
with pedigree file; (iv) allele 1 in base pairs (bp) and (v) allele 2 in bp. Any missing 
genotypes should be entered as ‘0`. When analysing data, the software will re-code these 
alleles numbering them consecutively as 1, 2 etc depending on the number of alleles 
observed for that marker in all genotyped individuals. The higher the number of alleles 
observed the higher the heterozygosity and thus the more informative that marker is.  
2.3.3 Running EasyLinkage analysis 
On the main screen of the GUI, we selected a ‘Single Locus` analysis, the linkage software 
(GENEHUNTER) and microsatellites project type. Next step was to select whether to 
perform a genome-wide analysis, one chromosome at a time or even to analyse small 
segments from a chromosome. Analysing small segments from a chromosome is useful to 
analyse large scale SNP data possibly analysing 500 markers in one segment. A lower LOD 
score was observed when analyzing a large number of markers, which would mean that for 
SNP analysis, it is better to avoid SNPs that are very close to each other. LOD scores were 
observed to be lower in such instances most likely due to allele frequencies used. It would 
be advisable to first analyse the whole chromosome for SNP analysis, and if significant 
results are observed, then re-analyse blocks of 100 markers at a time and as overlapping 
blocks. Another suggestion would be to use different and appropriate allele frequency 
algorithms, as will be described below.  
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After choosing the chromosomes, the sex-averaged deCode genetic map was selected to 
position the markers. There is a difference of approximately 10 cM between the male and 
female genetic maps, being longer in females due to a higher recombination rate. Other 
general options selected included ‘recode alleles` for continuous recoding of alleles within 
the marker files, Mendelian testing using PedCheck and the autoscale Y-axis  for LOD / 
NPL plots. 
Finally we chose the folder where the pedigree files were saved and the option to give 
individual pedigree results as well as totals. As decribed earlier, five different phenotype 
scenarios were used and each one had to be analysed using a different pedigree file. 
GENEHUNTER (GH) 
This computer package was developed to perform multipoint linkage analysis (parametric 
and non-parametric) in pedigrees of moderate size (Kruglyak et al., 1996). The program can 
compute LOD scores for pedigrees using a mode of inheritance and penetrance specified by 
user. It also allows the user to test for linkage under genetic heterogeneity. The multipoint 
NPL analysis tests for IBD allele sharing among affected individuals within pedigrees that is 
not affected by the mode of inheritance. It is thus ideal to be used for complex traits. GH 
also constructs the most likely haplotypes indicating crossovers even if there is missing data. 
A major advantage of GH over other statistical software, such as VITESSE and MLINK, is 
that it uses the Lander-Green algorithm and therefore it can perform multipoint analysis 
using several markers on a chromosome. Major drawbacks of GENEHUNTER include 
restrictions on pedigree size and its relatively slow speed when compared to similar 
software such as Allegro. Another limitation of GENEHUNTER is that it cannot analyse 
large number of markers which means that if one was analysing more than 100 markers on 
same chromosome, one would have to analyse these in groups of 100, repeating the analysis 
with different set sizes so as not to miss the signal. A recent version of GH can also perform 
transmission disequilibrium testing (TDT) analysis and analysis of quantitative traits 
making GH the ideal software to use for genetic analysis (Nyholt, 2001). In this study 
GENEHUNTER v1.2 was used to calculate Zlr scores using the Kong and Cox (1997) model. 
This algorithm addresses the problem encountered by previous versions of GENEHUNTER 
where NPL scores were found to be too conservative when inheritance data was incomplete. 
Another application used in this study was GENEHUNTER-MODSCORE v1.1 that 
maximises LOD scores with a series of penetrances and disease allele frequencies (Strauch et 
al., 2005).  
Using GENEHUNTER (GH) with EasyLinkage GUI 
Performing linkage analysis using GH through the Easylinkage GUI is easy and 
straightforward and saves time. After choosing the GENEHUNTER package software as 
described above, one has to go to Program Options from the main dashboard to be able to 
define a model for analysis. We analysed our data using both dominant and recessive 
models of disease. GENEHUNTEr v1.2 and GENEHUNTER-MODSCORE v1.1 were used 
for the analysis. A ‘Codominant` allele frequency algorithm was used for our analysis. 
EasyLinkage gives you four different algorithms to choose from. The Codominant algorithm 
was the best choice to use for extended families. This algorithm uses only alleles from 
genotyped individuals within the pedigree file. Frequencies of the alleles are calculated to 
sum up to 1, which means that if 5 different alleles were observed, then the allele frequency 
for each allele will be set to 0.200 or if 10 then to 0.100. If less than 5 alleles are found then 
still the frequency is set to 0.200. Other allele frequency algorithms include either all 
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individuals within the marker file or all individuals from pedigree file, both suitable for the 
affected sib pair (ASP) design. There are also specialised algorithms such as ‘founders only`, 
suitable only for pedigrees with large number of founders. SNP projects will use reference 
allele frequencies from different ethnic groups.  
As described before, we analysed our data using variable penetrances of disease starting 
with a highly pentetrant form (90%) down to 50%, for each scenario. Disease allele 
frequency was taken as 0.001 and the analysis steps between markers for multi-point 
analysis were set to 5, with recombination counting set to ‘On`. Penetrances were entered 
into the appropriate fields as described before, turning the haplotyping options to ‘on` and 
choosing the ‘Display all family plots`. The haplotyping option significantly increases the 
run time of the analysis but it creates plots for each family with haplotypes and marker 
positions together with other files that can be used by other software such as HaploPainter 
(Thiele & Nurnberg, 2004).  
3. Results 
3.1 Reading analysis files 
All analysis files were saved into an appropriately labelled folder with details of software 
used, allele frequency algorithm, pedigree file name, date and time of analysis. Data was 
saved as text and post-script format. The ‘.OUT` file within the ‘LOG` folder can be opened 
using Notepad where one can find all commands given to GENEHUNTER by EasyLinkage. 
If any errors were encountered and analysis was not completed, then one would find all 
information logged in, within this file. This file also includes detailed results such as LOD / 
NPL scores, marker information etc for each individual family and totals for all the families. 
EasyLinkage automatically commands GENEHUNTER to set up the maximum number of 
bits to be analysed within the family and to ‘trim` large families when needed. These two 
functions are needed to keep computations within the computer running ability due to 
memory limitations. Max Bits function is dependent on the number of meiosis being 
examined and represents 2N – F, where N is the number of non-founders and F is the 
number of founders. If, in the family there are 10 children (non-founders) from 2 sets of 
parents (4 founders), then max bits will be set to 16. If the family is larger, then the less 
informative individuals will be excluded from the analysis using the ‘trim` command. 
Automatically EasyLinkage also commands GENEHUNTER to use the Haldane map and 
there is no option to use the Kosambi map. The Haldane map does not assume interference, 
as described in a previous section. 
Figure 1A, shows the upper left hand quandrant of a parametric LOD score plot, including 
information such as allele frequency algorithm used, inheritance model, allele frequencies and 
penetrancies expressed as percentages. Markers are ranked in order of their most significant 
LOD / NPL scores with information about chromosome number, their position on the genetic 
map and calculated probability (Figure 1B). Figure 1C shows NPL results for a genome-wide 
analysis with NPL scores on the y-axis and chromosomal marker positions on the x-axis. Other 
plots are given for LOD scores, HLODs, p-values, Zlr scores and marker information. 
If the haplotyping option was chosen then a folder named ‘Haplotyping` is created and 
haplotype files for each pedigree are saved there. This haplotype data can then be imported 
to other software such as HaploPainter (Thiele & Nurnberg, 2004) to construct a graphical 
representation of the inherited haplotypes.  
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Fig. 1. Information given by parametric LOD score analysis plots (A & B) and genome wide 
NPL plot (C) 
3.2 Linkage results 
From the initial genome-wide scan using both families, evidence of linkage was observed to 
marker D11S1392, where the highest NPL score was of 5.77 (p=0.0006) and LOD/HLOD of 
2.55, for the dominant model with 90% penetrance and phenocopy rate of 1%. Fine mapping 
was performed by analysing four additional markers at this region (D11S4101, D11S935, 
D11S4102, and D11S1911) with average spacing of 1 to 1.5cM. Fine mapping confirmed 
linkage to marker D11S935 that is 52.94cM from 11p-telomere. Table 1 shows the highest 
scores obtained for this marker using the dominant mode of inheritance with 90% 
penetrance and phenocopy 1%. HLODs are calculated when more than one family are 
analysed together and thus the score can be different from the LOD if there is heterogeneity 
between families.  
Table 2 shows results obtained when analysing the same families assuming clinically 
unaffected individuals, whose BMD was measured by DEXA, as normal phenotype 
(according to WHO criteria) rather than having unknown phenotype (as in Table 1). NPL 
and Zlr scores were the same as observed in Table 1, but LOD and HLOD scores were 
different. 
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Phenotype LOD (cM) HLOD (α) NPL (p-val) Zlr 
Scenario I 2.90 (52.94) 2.90 (1.00) 7.00 (0.0014) 3.01 
Scenario II 2.46 (52.94) 2.46 (1.00) 4.02 (0.0038) 2.90 
Scenario III 2.89 (52.94) 2.89 (1.00) 7.23 (0.0013) 3.04 
Scenario IV 3.35 (52.94) 3.35 (1.00) 6.90 (0.0002) 3.74 
Scenario V 2.59 (52.94) 2.59 (1.00) 5.37 (0.0020) 3.28 
deCode map position in brackets in cM 
Table 1. Highest scores for marker D11S935 in both Pedigrees using an Autosomal 
Dominant Model after Fine Mapping 
This is because in the second analysis, shown in Table 2, based on current BMD 
measurements were defined as normal, individuals that might be osteoporotic in the future. 
These individuals might also be carrying the inherited causative allele and so will result in a 
false negative result if taken as normal. This is a common situation with complex and late 
onset disorders such as osteoporosis. 
 
Phenotype LOD (cM) HLOD (α) NPL (p-val) Zlr 
Scenario I  3.07 (52.94) 3.07 (1.00) 7.00 (0.0014) 3.01 
Scenario II  -0.19 (52.94) -0.00 (0.00) 4.02 (0.0038) 2.90 
Scenario III  2.97 (52.94) 2.97 (1.00) 7.23 (0.0013) 3.04 
Scenario IV 2.80 (52.94) 2.80 (1.00) 6.90 (0.0002) 3.74 
Scenario V  1.26 (50.64) 1.26 (1.00) 5.24 (0.0020) 3.28 
Table 2. Analysis of Chromosome 11 in Both Families Assuming Unaffected Individuals as 
Normal  
When calculating MOD scores for chromosome 11, the highest MOD was of 3.28 at the 
same region 52.94cM using the best calculated genetic model with penetrances 0.06 wild-
type homozygotes (6% phenocopy rate), 0.97 for both heterozygotes and mutant 
homozygotes. The disease allele frequency calculated at this model was of 0.000006 with a 
calculated population prevalence of 0.001%, assuming Hardy-Weinberg equilibrium. A 
MOD score of 4.33 (info = 0.87) was obtained when assuming imprinting with a disease 
allele frequency of 1 X 10-6. Estimated penetrances of wild-type homozygote (f +/+) 0.00; 
paternal heterozygote (f m/+) 0.00; and 1.00 for both maternal heterozygote (f +/m) and 
mutant homozygotes (f m/m) show evidence of paternal imprinting at this locus. Paternal 
imprinting indicates that the expression of the gene responsible for the disease at this 
locus may be entirely maternal. 
This locus was further analysed by varying the penetrance and phenocopy rates for the 
dominant mode of inheritance. Analyses were performed using phenocopies from 1% to 
20% and penetrance 0.7 – 0.5. The phenocopy rate is the percentage of individuals within the 
family that are clinically affected but do not carry the disease allele and hence their 
phenotype is due to other mainly environmental factors. As shown in Table 3, the highest 
LOD/HLOD score (3.32) was observed at penetrance of 0.8 and 0.7 with a 5% phenocopy. 
Changing the penetrances and hence the model, does not affect NPL scores (since these are 
model free) and therefore NPL scores are not shown in Table 3. 
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 Family 1 Family 2  
 LOD (cM)* NPL (p-val) Zlr LOD (cM)* NPL (p-val) Zlr 
Scenario I 1.92 (54.35) 6.26 (0.0078) 2.84 1.04 (52.48) 4.42 
(0.0098) 
2.41 
Scenario II 1.35 (55.77) 3.10 (0.0313) 2.12 1.18 (52.94) 3.06 
(0.0625) 
2.11 
Scenario III 1.92 (54.35) 6.26 (0.0078) 2.84 1.04 (51.56) 4.74 
(0.0117) 
2.27 
Scenario IV 1.64 (54.35) 4.41 (0.0156) 2.58 1.77 (52.94) 5.85 
(0.0156) 
2.75 
Scenario V 0.86 (48.21) 1.94 (0.1250) 1.63 1.75 (50.64) 5.83 
(0.0156) 
2.88 
Table 3. Multipoint LOD/HLOD Scores on Chromosome 11 under an Autosomal Dominant 
Model with Variable Penetrance and Phenocopy 
Although both families shared the same linkage interval, the highest LOD scores were 
obtained by two different markers with a spacing of approximately 4cM between them, 
showing also different inherited alleles, suggesting that different genes at the same locus, 
and within the same linkage interval, might be responsible for the same disease in different 
families (allelic heterogeneity). Highest LOD and NPL scores (1.77 and 5.9, respectively) 
were obtained for marker D11S1392 (50.64cM) for Family 2, while for Family 1 highest 
scores were obtained to marker D11S4102 (54cM) (Table 4). Inherited haplotypes identical 
by descent were observed in both individual families between markers D11S1392 and 
D11S935, with a number of recombination events defining boundaries for the linkage 

















0.9 3.07 3.25 3.05 2.78 2.47 
0.8 3.10 3.32 3.11 2.82 2.44 
0.7 3.12 3.32 3.08 2.73 2.23 
0.6 3.14 3.30 2.99 2.54 1.80 
0.5 3.17 3.25 2.84 2.17 1.07 
Table 4. Analysis of chromosome 11 for Families 1 & 2 after fine mapping * deCode map 
position in brackets in cM 
3.3 Choosing and sequencing candidate genes 
The locus indicated by both parametric and non-parametric linkage analyses on 
chromosomes 11p12 was scanned for known candidate genes. Candidate genes within the 
linkage interval were selected with prior knowledge of physiology using the NCBI map 
viewer (http://www.ncbi.nlm.nih.gov/mapview/) Homo sapiens build 36. The online 
application GeneSeeker v2.0 (http://www.cmbi.kun.nl/GeneSeeker) was also used. A new 
online tool GeneDistiller (http://www.genedistiller.org/) was recently developed to filter 
genes within a specified linkage interval is (Seelow et al., 2008). When using NCBI 
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MapViewer to select the genes manually, one has to align the genes with the corresponding 
genetic map (e.g. deCode), setting the resolution of the map to 1 cM for accurate alignment. 
Applications such as GeneDistiller can facilitate this process since they automatically extract 
all genes within a given interval. It is also advisable to search for genes further away from 
both ends of the linkage interval even up to 5 – 10 cM. This will compensate for differences 
in positioning of markers on the genetic map and the actual physical map. 
The whole area from 49 to 55cM on chromosome 11 (deCode genetic map) was searched for 
genes that might plausibly be involved in the disease. More than twenty genes and 
hypothetical proteins are found in this region, with the best candidates being the tumour 
necrosis factor receptor-associated factor 6 (TRAF6) gene [MIM 602355] and the CD44 gene 
[MIM 107269] (sequenced in Family 2) found 1cM away from D11S1392 (~51cM).  TRAF6 
was sequenced in both families but it was closer to D11S4102 showing highest scores in 
Family 1.  
Oligonucleotide primers were designed using the online application Primer 3 
(http://frodo.wi.mit.edu/primer3/) (Rozen and Skaletsky, 2000) to amplify all coding 
regions including intron-exon boundaries and promoter region of the CD44 gene using 
transcript ENST00000278385) from the ENSEMBL database (http://www.ensembl.org). 
Transcript ENST00000313105 was used for TRAF6 gene. Due to limitations of the 
sequencing technique, only fragments from 200 to 600bp were amplified by PCR. Large 
exons and up to 1500bp of the 5` untranslated region were covered by overlapping PCR 
fragments. Bidirectional DNA sequencing was performed using standard techniques and 
fluorescent capillary electrophoresis. 
3.4 Reading and Interpretation of sequencing results 
DNA sequencing results were compared to reference sequences in public databases by using 
the software ChromasPro v1.33 (http://www.technelysium.com.au) that directly searches 
the BLAST application on NCBI. Variations that did not agree with the reference sequence 
were confirmed by the reverse sequence. Electropherograms were also printed and checked 
manually.  
Detailed information about specific genes including information about known 
mutations/polymorphisms and gene expression was obtained from GENECARDS 
(http://www.genecards.org) and The Human Gene Mutation Database 
(http://www.hgmd.cf.ac.uk/). When identifying a variation, the first step is to check using 
databases whether it is already known. Information about individual SNPs can be searched 
in gene and SNP databases such as the NCBI SNP database 
(http://www.ncbi.nlm.nih.gov/projects/SNP/). A list of SNP databases can be found at 
http://www.humgen.nl/SNP_databases.html. If the variation is a known SNP, then one 
has to refer to it using the database reference number such as ‘rs3830511`. In the database 
one can find information about individual SNPs including any population frequencies. The 
next step is to identify the frequency of these variations in the local population and 
determine whether it is a rare or common variation. To perform population screening, one 
can use techniques such as restriction fragment length polymorphism (RFLP), real-time PCR 
or direct DNA sequencing in a random sample from the general population. For our studies, 
random samples of DNA were obtained from newborns and used for this purpose, followed 
by a small scale case-control study using osteoporotic and normal post-menopausal women. 
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Virtual restriction fragment length polymorphism (RFLP) gel electrophoresis was carried 
out using the online web applications NEBcutter V2.0 (http:// tools.neb.com 
/NEBcutter2/index.php) to test the identified polymorphisms. 
3.4.1 TRAF6 Sequencing and functional assays  
Following direct sequencing, three different variants were identified when compared to 
reference sequences on the NCBI and Ensembl databases. An A to T transversion was 
identified at position -721 (5` upstream of exon 1), when compared to TRAF6 reference 
sequence (AY228337). This variant had not been previously described. Following 
sequencing of all family members, three affected individuals from Family 1 were observed 
to be heterozygous for this variant. Individuals from Family 2 were all wild-type 
homozygotes. RFLP was carried out in 82 unrelated postmenopausal women. This variant 
was observed to be very rare within an unrelated group of postmenopausal women, as only 
three heterozygotes were observed. After screening 350 chromosomes in a random sample 
from the general population, only 2 alleles were observed (0.57%) with this variant having a 
population frequency of 1.1%.  
A previously described insertion/deletion of a T in the intron between exons 4 and 5, in the 
polyT region, sixteen base pairs ahead of the exon-intron boundary (rs3830511), was also 
identified. When analysing all family members and controls, only three individuals were 
observed to be heterozygotes for this insertion/deletion, one of whom was severely affected 
and the other two were normal individuals.  
A transition from G to A was found in the intron between exons 6 and 7, 110bp upstream of 
the exon-intron boundary. When sequencing all members from both families, four 
heterozygotes for this variant were identified, and the rest were homozygous for the wild 
type allele G. Three of the four heterozygous individuals for this variant had a low BMD, 
two of whom were also heterozygous for the T insertion/deletion described above. 
Genotyping by RFLP (PvuII) was performed in 82 unrelated postmenopausal women. 
Genotype frequencies observed were 72.3% GG, 26.5% GA and 1.2% AA.  
Although the -721 A/T polymorphism was not linked to the inherited haplotype within 
Family 1, this polymorphism was rare within the population and it was thus hypothesised 
that it could affect gene expression. The TRAF6 gene plays a major role in osteoclast 
differentiation and activation and plays an important role in osteoimmunology (ref).To 
test this hypothesis the TRAF6 gene promoter region, harbouring the -721 variant, was 
analysed for possible transcriptional factor binding sites in the presence and absence of 
the variant identified in this study, using the online application MatInspector by 
Genomatix Software GmbH(http://www.genomatix.de/online_help/help_matinspector/ 
matinspector_help.html) (Cartharius et al., 2005). The whole sequence, up to 1500bp 
upstream from the transcriptional start, site was thus copied and tested using the 
MatInspector online application. Free registration was needed to use this application for 
academic use allowing twenty analyses per month. Both normal and mutated sequences 
were used and analysis was performed using a vertebrate matrix. When comparing 
normal and mutated alleles it was observed that position -721 might be a potential 
binding site for nuclear factor Y (NF-Y), a CCAAT binding factor, that binds to the wild-
type allele but not to the mutated one. Non-binding of this factor would result in a 
decreased expression of the gene.  
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Three different sized fragments from the promoter region of TRAF6 (up to 1500bp) were 
cloned into a luciferase reporter vector and transfected into two types of mammalian cells. 
After measuring luciferase activity in both cell lines, it was evident that gene expression was 
affected by the -721 variant found in the TRAF6 gene promoter. Expression of the mutated 
allele was observed to be as low as 5% that of the normal allele expressed in murine 
macrophages. The two longer constructs showed higher expression for the mutated allele 
suggesting that other transcriptional factors most likely interact either directly or with other 
factors at the mutated site. Although these observations suggest that this variant affects a 
transcriptional factor binding site and thus could increase the risk for osteoporosis, further 
research is needed to identify the molecular mechanisms. 
3.4.2 CD44 gene sequencing in family 2 
DNA sequencing of the CD44 gene found on chromosome 11p12 was performed in Family 2 
since this gene is found closer to D11S1392, which shows the highest LOD scores within this 
family, as described above. Osteoclast formation was inhibited by CD44 antibody 
suggesting its important role in bone physiology and as a potential therapeutic target for 
metabolic bone disease (Kania et al., 1997). As well, CD44 was also associated with 
inflammatory bone loss (Hayer et al., 2005). 
Sequencing CD44 revealed a number of intronic sequence variants, including two A/G 
changes (rs4756196 and rs3736812) and an A/C transversion in intron 16, none of which 
were observed to be inherited with the linked marker. A number of other variants were 
found in coding regions, including an A/G (rs9666607) and C/T (rs11607491) changes in 
exon 10, both resulting in an amino acid change,  which were not linked with the inherited 
haplotype. Another C/T synonymous variant (rs35356320) was detected in three affected 
and one unaffected individual. A non-synonymous variant found in exon 12 (rs1467558) 
was only found in two affected members of this family. 
An interesting variant was detected in exon 9, a synonymous G/A transition (rs11033026), 
found 32 nucleotides upstream from the exon/intron junction. Sequencing the gene in all 
members of this family, revealed that all individuals carrying the linked STR allele 3 (Figure 
1B) for marker D11S1392 were also heterozygous for this variant, suggesting that the two 
were linked. 
As shown in Figure 1B, all affected members, with the exception of one phenocopy 
(III:4), were heterozygous for both the STR allele and the A allele. This variant was not 
found in any of the non-affected family members, with the exception of two who also 
carried the linked STR allele (III:2 and III:7) (incomplete penetrance). The minor allele 
frequency within the Maltese population was determined to be 0.012 (1.19%) with a 
population frequency 2.38%. According to the NCBI dbSNP database 
(http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11033026), and HapMap, this 
frequency compares with that found in Sub-Saharan Africans, African-Americans and 
Han Chinese from Beijing (minor allele frequencies 0.336, 0.115, 0.012, respectively), and 
was absent in European Caucasians.  This suggests a founder effect in the Maltese 
population, complementing other previously reported studies on other human diseases 
(Farrugia et al., 2007; Koziell et al., 2002).  
Since this variant was found in an exon but does not result in an amino acid change, we 
hypothesised that it could affect pre-mRNA splicing resulting in a different protein isoform. 
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To test this hypothesis at the transcriptional level an online Bioinformatics predictive tool 
was used to identify any possible exon splicing enhancers (ESEs) at this region as described 
by Cartegne et al (2002) (http://rulai.cshl.edu/tools/ESE2/index.html) . The G/A variant 
was found to abolish an ESE motif (TGAGGA > TGAAGA) for the SR protein (SRp55) with 
a score of 2.817 (threshold 2.676), in the presence of the A allele. Another online application 
RESCUE-ESE (http://genes.mit.edu/fas-ess/) did not predict any possible ESEs at this 
locus (Wang et al., 2004).  
The experimental approach to test this hypothesis involved the use of an in vitro exon-
trapping vector where the whole exon 9 and adjacent introns were inserted into a vector 
yielding a hybrid construct made up of two vector β-globin exons flanking CD44 exon 9 and 
adjacent introns. Following transfection into mammalian cells, the construct was transcribed 
under the control of a SV40 promoter and spliced. The mRNA derived from this construct 
was extracted and reverse transcribed followed by specific amplification using cDNA as 
template and specific primers to β-globin exons (SD6 and SA2). The spliced transcripts were 
analysed by agarose gel (Vidal et al., 2009).  Our results showed that in the presence of the A 
allele only one transcript (261bp) was weakly amplified in both COS-7 and HeLa cells and 
was completely absent in RAW264.7 macrophages. DNA sequencing confirmed that this 
transcript did not contain any part of CD44 exon 9, and was entirely made up of vector exon 
sequences, suggesting skipping of exon 9.  Two transcripts were amplified in the presence of 
the G allele (378bp and 261bp). 
4. Conclusion 
In this study, two polymorphisms with a population frequency of less than 5.0%were 
identified by linkage analysis in two extended Maltese families with a highly penetrant form 
of osteoporosis. In vitro functional studies confirmed that these polymorphisms might 
increase the individual’s susceptibility to osteoporosis. This study adds to the existent 
knowledge of the complex pathophysiology involved in disorders such as osteoporosis. This 
knowledge is useful for the development of more targeted and individualised treatments. 
Our results added to the increasing evidence that rare but functional polymorphisms are 
also responsible for disorders such as osteoporosis, and also that using extended families 
with extreme phenotypes increases the chance to identify the responsible genes. Computer 
technology and the internet contribute significantly to the outcome of these studies. Both 
technologies were important tools for researchers throughout the whole study starting from 
planning and design of experiments, analysis of data and interpretation of results. 
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Glossary Allele Alternative states of genes only identical 
if their base sequences are identical 
Body Mass Index 
(BMI) 
A statistic of the relationship between 
weight and height = body weight 
divided by height squared  
Bone mineral 
density (BMD) 
A measure of bone density usually 
measured by x-ray techniques 
Haplotype A set of variants (SNPs or STRs) that are 
inherited together as a single block on a 
linear chromosome 
Imprinting Expression of genes depending upon 




Groups of markers or genes on the same 
linear chromosome that are inherited 
together more often than expected by 
chance as long as genetic recombination 
does not take place between them. LD 




Variability of chromosomal regions 
involved between different subjects 
Penetrance The percentage of individuals that 
express a trait determined by gene/s 
Phenocopy A phenotyping change that mimics the 
expression of a mutation usually 
resulting from effects of the 
environment 
Segregate Separation of homologous 
chromosomes at random during meiosis 
SNP A difference in a single nucleotide at a 
particular DNA site 
STR Short tandem repeat variations differing 
between different individuals in the 
number of repeated sequences eg: 
(CACACA) or (CACACACACA). Used 
as markers in forensics for 
identification. 
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